JB-22, I didn't imply ADXS had no other partnerships that will help it advance its therapies, I was only responding to Peke that the SELLAS deal only covers Lm+WT1, which is good because it is a limited deal that barely encumbers ADXS's platform.
You are correct, but I think you may have mistook the point I was making. Peace.